Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2021.098 | 30 years journey of survivorship of primary total hip replacement in Hong Kong |
Dr. LIU Samson Wing Hong 廖泳康 |
| 2023.407 | 3D histologic and immunohistochemical staining for tissue reconstruction and pathological diagnosis |
Dr. LI Joshua Joshua Li |
| 2017.397 | 3D Printing Technology For Planning Left Atrial Appendage Occlusion: A Randomised Trial |
Prof. LEE Alex Pui Wai 李沛威 |
| 2015.536 | 3D surgical planning and Patient Specific Instruments (PSIs) can achieve good accuracy for complex bone resections in bone sarcoma patients. | Dr. WONG Kwok Chuen |
| 2005.261 | 3D Ultrasound Biometry of Pelvic Floor in Postpartum Women | YIP Shing Kai |
| 2017.025 | 3D-printed Surgical Instruments and Orbital Models (3SIOM) |
Dr. CHONG Kelvin Kam Lung 莊金隆 |
| 2022.249 | 3D-Ultrasound-Guided Transperineal Microwave needle ablation for men with symptomatic benign prostatic hyperplasia |
Dr. CHIU Peter Ka Fung 趙家鋒 |
| 2008.244 | 4-(Methylnitrosamino)-1-(3-pyridy1)-1 Butanone, a Tobacco-specific Carcinogen Promotes the Growth of Lung Cells via Inhibiting the Activation of PPAR Gamma | Professor Chen George |
| 2017.314 | 5-Aminolevulinic Acid Fluorescence Guided Resection of Malignant Glioma: Hong Kong Experience |
Dr. CHAN Danny Tat Ming 陳達明 |
| 2020.530 | 5-Year Cardiovascular Event Risk in Early Rheumatoid Arthritis Patients who received Treat-to-Target Management: a population-based cohort study |
Prof. TAM Lai Shan 譚麗珊 |
| 2008.550 | 5-year clinical outcome of clients presenting to a territory-wide Elderly Suicide Prevention Program (ESPP) 2002-2006 | Prof Chan Sau Man Sandra |
| 2007.296 | 5-Year Stability of ICD-10 Psychiatric Diagnoses in Patients Presented with First Episode Psychosis to the EASY (Early Assessment Service for Young People with Psychosis) Program in HKSAR | CHANG Wing Chung |
| 2016.011 | 7-year Follow-up of the Jockey Club Early Psychosis (JCEP) Project Early Intervention Trial for First-episode Psychosis |
Dr. CHUNG Dicky WS 鍾維壽醫生 |
| 2019.366 | A 'Sweet Dream - Sugar Down' (SD-SD) programme to promote sleep and better glycaemic control in patients with type 2 diabetes mellitus. |
Ms. NGAN Hau Yi 顏巧尔 |
| 2024.169 | A 10-year Cluster Based Retrospective Cohort Study of Patients with AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) in Hong Kong | Dr. CHOI Chun Ho Joseph |
| 2013.011 | A 10-year follow-up study on obstructive sleep apnoea in a population-based cohort: a cardiovascular perspective | Prof Li Albert Martin |
| 2015.698 | A 10-year Naturalistic Follow-up Study of Insomnia in Major Depressive Disorder - Focusing on Clinical and Neuropsychological Outcomes |
Prof. WING Yun Kwok 榮潤國 |
| 2011.026 | A 10-year outcome study of an early intervention program for psychosis in Hong Kong (EASY) compare with standard care service | Dr Chung Wai Sau |
| 2017.611 | A 12-week randomized, patient and investigator blinded, placebo-controlled, parallel group study to investigate the efficacy of LIK066 in obese patients with non-alcoholic steatohepatitis (NASH) |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2008.416 | A 12-week Treatment, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Indacaterol (150 and 300 ug o.d.) in Patients with Chronic Obstructive Pulmonary Disease (COPD) | Prof. Hui Shu Cheong |
| 2005.139 | A 12-week, Double-Blind, Randomized Study to Investigate the Effect of 500_g Roflumilast Tablets Once Daily Versus Placebo on Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease | Prof. Hui Shu Cheong David |
| 2002.284 | A 12-week, Randomized, Double-blind, Parallel-group, Multicentre, Phase III Study to Compare the Efficacy and Safety of Symbicort ® pMDI (Budesonide/Formoterol 80/4.5ug 2 Actuations b.I.d., Delivered Dose) with that of Pulmicort ® pMDI (Budesonide100ug 2 Actuations b.I.d., Metered Dose) and Symbicort Turbuhaler ® (Budesonide/Formoterol 80/4.5 ug 2 Inhalations b.I.d., Delivered Dose) in Children with Asthma | Prof. Wong Wing Kin Gary |
| 2007.427 | A 12-week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Dose-Finding Study to Evaluate the Efficacy, Tolerability and Safety of Fesoterodine in Comparison to Placebo in Patients with Overactive Bladder | Dr PANG Selina |
| 2009.147 | A 12-year followup study of bone changes in Chinese women - the Hong Kong Perimenopausal women osteoporosis study | Prof. Ho (Chan) Suzaanne Sutying |
| 2020.101 | A 120-months review of the autopsy rate and discordant rates in a university-affiliated teaching hospital in Hong Kong | Dr. CHAN Ronald Cheong Kin |
| 2006.233 | A 13-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety and Tolerability of Pregabalin (150-600 MG/DAY) Using A Flexible Dosing Schedule in the Treatment of Subjects with Central Post-Stroke Pain (CPSP) | Prof. Wong Ka Sing Lawrence |
| 2012.281 | A 14 week, randomized, double-blind, multi-center, parallel group, active controlled study to evaluate the efficacy and safety of LCZ696 in comparison to olmesartan in elderly patients with essential hypertension | Prof. Tomlinson Brian |
| 2007.138 | A 16 Week Open-Label Outpatient, Randomized, Parallel Study Assessing the Impact of Two Different Initial Dose Prescriptions for Dry Powder Inhaled Insulin (EXUBERA_) on Glycemic Control in Patients with Type 2 Diabetes Mellitus Who are Poorly Controlled on A Combination of Two or More Oral Agents | Prof. Tong C.Y. Peter |
| 2009.234 | A 17-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial Of Pregabalin For The Treatment Of Chronic Central Neuropathic Pain After Spinal Cord Injury | Associate Consultant Law Sheung Wai |
| 2008.153 | A 2 year extension to: A 76-week, Worldwide, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Tolerability and Efficacy of Anacetrapib When Added to Ongoing Therapy with a Statin in Patients with Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease: Reversal period extended from 12 weeks to 1-year | Professor Tomlinson Brian |
| 2013.069 | A 2-Part, Phase 2/3 Study to Assess the Safety, Tolerability and Efficacy of AMG 145 in Subjects With Homozygous Familial Hypercholesterolemia Part A - Open-label, Single-arm, Multicenter Pilot Study to Evaluate Safety, Tolerability, and Efficacy of AMG 145 in Subjects With Homozygous Familial Hypercholesterolemia Part B - Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of AMG 145 in Subjects With Homozygous Familial Hypercholesterolemia | Professor Tomlinson Brian |
| 2011.309 | A 2-year Observational Study on Eyelid Bags in Chinese: Analysis on anatomical components and progression | Professor Lam Dennis Shun Chiu |
| 2005.257 | A 2-Year Study to Assess the Efficacy, Safety, and Tolerability of Taranabant in Obese Patients Followed by a 1-Year Extension | Dr. Chow Chun Chung Francis |
| 2022.492 | A 20-year follow-up study of clinical, functional and neuro-biological outcomes first-episode schizophrenia spectrum and bipolar affective disorders. |
Dr. WONG Yip Chau 黃業就 |
| 2003.263 | A 24 Weeks, Multi-Centre, Randomized, 2-Arm Parallel, Open-Labelled Study to Investigate the Efficacy and Safety of Initiating Biphasic Insulin Aspart 30 (BIAsp 30) in Type 2 Diabetes Patients Currently Not Achieving Treatment Targets with Oral Anti-Diabetes Drugs Alone (BIAsp-3021, Phase IV) | Dr. Chow Chun Chung Francis |
| 2019.451 | A 24-week multi-center, double-blind, placebo controlled dose-range finding study to investigate the efficacy and safety of oral QBW251 in COPD patients on triple inhaled therapy (LABA/LAMA/ICS) |
Prof. HUI David Shu Cheong 許樹昌 |
| 2004.182 | A 24-Week Randomized, Double-blind, Double-dummy, Multicenter Study to Compare the Efficacy of Extended Release AVANDIA_ (8mg OD) and Immediate-Release AVANDIA (8mg OD) in Subjects with Type 2 Diabetes Mellitus | Prof. Chan C.N. Juliana |
| 2005.022 | A 24-week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Active-Controlled (Metformin or Metformin Combined with Fenofibrate) Study to Evaluate the Lipid Metabolic Effects, Safety and Tolerability of Tesaglitazar Therapy in Patients with Type 2 Diabetes and Low HDL-Cholesterol on a Fixed Background Therapy with a Statin | Prof. Kong PS Alice |
| 2010.347 | A 24-week, multi-center, double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy and safety of vildagliptin 50mg bid as an add-on therapy to insulin, with or without metformin, in patients with type 2 diabetes mellitus | Dr. Risa Ozaki |
| 2015.370 | A 24-week, multinational, multicentre, randomised, open label, parallel-group treat to target trial to compare efficacy and safety of thrice daily versus twice daily NovoMix®30 (Biphasic insulin aspart 30) in subjects with type 2 diabetes inadequately controlled with basal insulin |
Dr. CHOW Francis Chun Chung 周振中 |
| 2005.063 | A 26 Week, Double-blind, Randomized, Multicenter, Parallel Group, Active-controlled Study Comparing Aliskiren to Ramipril with Optional Addition of Hydrochlorothiazide, Followed by a 4 Week Double-blind, Randomized, Placebo-Controlled Withdrawal in Patients with Essential Hypertension | Prof. Yu Cheuk Man |
| 2016.058 | A 2D-3D Modeling Scheme for 3D Lung Reconstruction Derived from Low Dose Biplanar X-ray in Standing Position- with Clinical Validation in Adolescent Idiopathic Scoliosis |
Prof. CHU Winnie Chiu Wing 朱昭穎 |
| 2017.336 | A 3 year longitudinal study of the level of asthma control and treatment of asthma patients in Hong Kong |
Dr. CHAN Ka Pang 陳嘉鵬 |
| 2006.221 | A 3-month Epidemiological Study to Establish Characteristics of Asian Patients with Acute Major Depressive Disorder | Prof. Wing Yun Kwok |
| 2019.258 | A 3-year prospective study of offspring of patients with bipolar disorder: determining emergence of mood disorder and predictive value of circadian rhythm disturbance | Dr. ZHANG Jihui |
| 2006.025 | A 3-year, Double-blind Extension to CZOL446H2301 to Evaluate the Long Term Safety and Efficacy of Zoledronic Acid in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D | Prof. Leung Ping Chung |
| 2009.017 | A 3-Year, Multicenter, Double-blind, Randomized, Placebo-Controlled Extension to CZOL446H2301E1 to Evaluate the Efficacy and Long Term Safety of 6 and 9 Years Zoledronic Acid Treatment of Postmenopausal women with Osteoporosis | Prof. Leung Ping Chung |
| 2017.636 | A 3D Software and Bone Quality Assessment Validation of Low Dose Biplanar X-ray EOS Imaging System based on Retrospective Collected Imaging Data |
Prof. CHENG Jack Chun Yiu 鄭振耀 |
| 2015.110 | A 40-year-old question – what is the functional receptor for human norovirus? |
Dr. CHAN Martin Chi Wai 陳子蔚 |
| 2013.568 | A 48 weeks, phase II, randomized, double-blind, placebo-controlled, proof of concept and dose finding study of three different dose regimens of BI 655066 administered subcutaneously in patients with ankylosing spondylitis. | Prof. TAM Lai Shan |
Page 2 of 254.